findmyKOL
Clinical trialNCT04251403UnknownEarly phase 1Interventional

Novel Approach to Surveillance of Gastric Lesions

SponsorNew York Presbyterian HospitalEnrollment10Atrophic GastritisGastric CancerGastric DysplasiaIntestinal Metaplasia of Gastric Mucosa
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Charles Lightdale, MD

    New York Presbyterian - Columbia University Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2020
Primary completion
28 Feb 2021
Completion
28 Feb 2021
Last update posted
31 Jan 2020
Registered enrollment
10
Registry id
NCT04251403

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.